AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 99 filers reported holding AKERO THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $75,723,196 | -39.5% | 1,621,829 | -50.4% | 32.88% | -35.0% |
| Q1 2023 | $125,180,178 | +69717.6% | 3,271,829 | 0.0% | 50.58% | -11.3% |
| Q4 2022 | $179,296 | -99.9% | 3,271,829 | -33.3% | 57.03% | +20.9% |
| Q3 2022 | $167,112,000 | +260.3% | 4,907,829 | 0.0% | 47.17% | +143.0% |
| Q2 2022 | $46,379,000 | -33.4% | 4,907,829 | 0.0% | 19.41% | +4.7% |
| Q1 2022 | $69,642,000 | -32.9% | 4,907,829 | 0.0% | 18.54% | -19.3% |
| Q4 2021 | $103,801,000 | – | 4,907,829 | – | 22.97% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 5,830,203 | $169,134,000 | 18.83% |
| venBio Partners LLC | 2,444,311 | $70,909,000 | 6.74% |
| Versant Venture Management, LLC | 617,727 | $17,920,000 | 3.49% |
| Redmile Group, LLC | 2,513,746 | $72,924,000 | 1.03% |
| Boxer Capital, LLC | 831,495 | $24,122,000 | 0.82% |
| Integral Health Asset Management, LLC | 85,000 | $2,466,000 | 0.70% |
| Vivo Capital, LLC | 673,280 | $19,532,000 | 0.69% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 32,000 | $928,000 | 0.51% |
| Cormorant Asset Management, LP | 742,549 | $21,541,000 | 0.48% |
| HHLR ADVISORS, LTD. | 1,656,673 | $48,060,000 | 0.48% |